Orjan Akerborg

Summary

Publications

  1. doi Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland
    Orjan Akerborg
    OptumInsight, Stockholm, Sweden
    Clin Ther 34:1788-802. 2012
  2. doi Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland
    Jonas Nilsson
    OptumInsight, Stockholm, Sweden
    Eur J Health Econ 14:481-93. 2013

Detail Information

Publications2

  1. doi Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland
    Orjan Akerborg
    OptumInsight, Stockholm, Sweden
    Clin Ther 34:1788-802. 2012
    ..According to results in the ATHENA trial, dronedarone on top of standard of care (SOC) decreases the risk of cardiovascular hospitalizations or death by 24% compared with SOC alone...
  2. doi Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland
    Jonas Nilsson
    OptumInsight, Stockholm, Sweden
    Eur J Health Econ 14:481-93. 2013
    ..The most significant driving factor for the cost-effectiveness of dronedarone is the increased survival rate for patients on dronedarone...